ADERTA BIOTECNOLOGIA SL
Company details
- Active NIF/CIF: B01446624
-
Telephone: Not available
-
Date of last BORME entry: 03/12/2010
-
Sector: Financial and Insurance Activities
-
Address: C/ GENERAL ALAVA Nº 10 PRIMERO OFICINA 3 (VITORIA-GASTEIZ)
-
Website: Not available
-
Featured products:
More information on ADERTA BIOTECNOLOGIA SL
-
03/12/2010 | BORME act no.: 1123909 | Register: ÁLAVADepósito de cuentas anuales (Noviembre de 2010) -
19/10/2010 | BORME act no.: 847991 | Register: ÁLAVADepósito de cuentas anuales (Septiembre de 2010)
-
21/04/2010 | BORME act no.: 166202 | Register: ÁLAVADepósito de cuentas anuales (Marzo de 2010)
-
22/09/2008 | BORME act no.: 440628 | Register: ÁLAVAConstitución
-
22/09/2008 | BORME act no.: 440628 | Register: ÁLAVADeclaración de unipersonalidad
-
22/09/2008 | BORME act no.: 440628 | Register: ÁLAVANombramientos
Other information
The CIF of ADERTA BIOTECNOLOGIA SL is B01446624 and its business status is active. Its economic activity belongs to the CNAE 6499 - Other financial services, except insurance and pension funds n.e.c. Its SIC is 8011 - Equipo y suministros odontológicos.
ADERTA BIOTECNOLOGIA SL has Between 10 and 49 employees employees and an annual turnover of less than 2 million euros. The company is registered in the Mercantile Registry of álava. It has a total of 2 registration charges. Its latest announcement in Borme was published on 03/12/2010 and its last deposit of ordinary annual accounts is from the year -.
You can check the contact details of ADERTA BIOTECNOLOGIA SL such as phone number, address, or website in the Company Data module.
For more information about ADERTA BIOTECNOLOGIA SL, you can acquire one of our available financial reports, the Annual Accounts of the company, or check its payment incidents in the RAI delinquency file.
All the financial, business, and legal information we provide about ADERTA BIOTECNOLOGIA SL comes from official sources and is updated daily.
Do you want to know more about ADERTA BIOTECNOLOGIA SL??
Find out more about this company by consulting these reports:
